Our History Can Change the Future of CNS Therapy

In 1990, Pharmavene was founded as a stand-alone development organization. In 1997, it was acquired by Shire and became Shire Laboratories, Inc., a US subsidiary of Shire plc. In December 2005, Supernus Pharmaceuticals, Inc. was established, after acquiring substantially all of the assets of Shire Laboratories, Inc.

Carbatrol and Adderall XR are registered trademarks of and marketed by Shire US Inc.
Intuniv is a registered trademark of and marketed by Shire LLC.
Oracea is a registered trademark and marketed by Galderma Laboratories, L.P.
Sanctura XR is a registered trademark and marketed by Allergan, Inc.